Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
By S. Hadinegoro, J. Arredondo-García, M. R. Capeding, C. Deseda, T. Chotpitayasunondh, R. Dietze, H.I. Hj Muhammad Ismail, H. Reynales, K. Limkittikul, D. M. Rivera-Medina and 14 more. New England Journal of Medicine, 2015
1,000 citations recorded by the source corpus.
Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/92702ee4877b8d195f5cec7959e156bedcfb05ec
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Public Health, Environmental and Occupational Health
Citations in the corpus
- HLA variation and disease (2018, background): “Emerging infections, such as Ebola, Zika and Dengue viruses, highlight the need for rapid vaccine generation and trialling strategies that rely on the efficient identification of appropriate viral epitopes to safely but effectively induce immunogenicity 106,107 .”
- Antibody-dependent enhancement of severe dengue disease in humans (2017, background): “Sex, epidemic season, age (2-4, 5-9, 10-14) and number of previous infections (0, 1, ≥2) were included as covariates (covariate coefficients in tables S6, S9 to S11).”